Tag: Spacer
-
Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis
Condition: AsthmaIntervention: Drug: salbutamol sulfate + ipratropium bromideSponsor: Boehringer IngelheimTerminated – verified July 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
CLINICAL PHARMACOLOGY STUDY OF A FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE 50µg PLUS FORMOTEROL FUMARATE 6 µg VERSUS THE FREE COMBINATION OF BECLOMETHASONE HFA pMDI AND FORMOTEROL HFA pMDI AVAILABLE ON THE MARKET USING THE AEROCHAMBER PLUS™ SPACER DEVICE IN ASTHMATIC CHILDREN
Condition: AsthmaInterventions: Drug: CHF1535 pMDI + AC Plus; Drug: BDP and Formoterol + AC PlusSponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.Completed – verified April 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
Inhaler spacer devices to treat asthma in children – Nursing Times
Inhaler spacer devices to treat asthma in childrenNursing TimesDrawing on literature searches and professional experience, this article discusses the treatment of asthma with pressurised metered dose inhalers (pMDIs). It demonstrates the need for pMDIs, and presents the health and cost benefits of using a pMDI … View full post on asthma – Google News
-
Managing asthma: the importance of spacer – Riverhead LOCAL
Managing asthma: the importance of spacerRiverhead LOCALAsthma is one of the most common chronic conditions in the nation with an incidence rate of one in 9 children and one in 12 adults in NY state. The highest rate of asthma occurs in NYC, Nassau and Suffolk counties. Studies have demonstrated that more … View full…
-
School nurse invents new asthma spacer – Nursing Times
School nurse invents new asthma spacerNursing TimesA Norfolk school nurse has won a prestigious award for inventing a “pocket sized” asthma spacer. Paul Watson, a school nurse from Norfolk Community Health and Care NHS Trust, received the 2011 Alumni Success in BusinessAward from Anglia Ruskin … View full post on asthma – Google News
-
Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers
Condition: AsthmaInterventions: Drug: Seretide 250(8puffs) via Evohaler actuator; Drug: Seretide 250 (8 puffs)/placebo via Volumatic spacer; Drug: Seretide 250/placebo 8 puffs via Aerochamber Plus spacer; Drug: Seretide 250/placebo via Synchro-BreatheSponsor: University of DundeeCompleted – verified December 2009 View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days